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Newcastle disease (ND) strain I-2 vaccine flakes were formulated by using an amorphous trehalose 
sugar as a stabilizer and evaluated for long term storage and delivery to chickens. The results showed 
that the I-2 virus stored in trehalose flakes maintained its infectivity titre at 108.6 EID 50/0.1 mL for 4 
weeks at ambient room temperature. The vaccine flakes were stable after storage for 16 weeks while 
maintaining the infectivity titre of 107.5 EID 50/0.1 mL. The results further indicated that the infectivity 
titres for ND virus recovered from flakes and liquid vaccine were similar. The findings from the present 
study showed the vaccine flakes are easily transported and readily released into a fluid phase when 
mixed with water; they can be administered orally without mixing with feeds and hence suitable for 
individual or mass vaccination of semi-feral scavenging village chickens. Chickens vaccinated orally 
with the flakes developed antiviral antibodies and resisted challenge with virulent strain of ND virus. 
The formulation of trehalose vaccine flakes could be a useful way to store and deliver ND vaccines to 
village chicken flocks in rural areas, particularly in developing countries if it is optimised. 
 





Newcastle disease (ND) is a serious contagious disease 
that causes high morbidity and mortality in poultry, espe-
cially in village chickens in developing countries (Sprad-
brow and Copland, 1996). ND may cause up to 100% 
mortality thus destroying entire chicken flocks. The disea-
se is a major hindrance to the development of village 
chicken industry particularly in developing countries 
(Spradbrow, 1992). Control of ND is therefore of para-
mount importance. 
Vaccination has a major impact on preventing and 
controlling the outbreaks and spread of ND (Meulemans, 
1988). However, most ND live vaccines currently in use 
are heat labile and require expensive cold chain, which 
are important limiting factors for controlling ND and con-
sequently the productivity of village chickens (Spradbrow, 
1992). The above mentioned problems can be overcome 
by having low cost vaccine delivery system which could 
be operated by chicken keepers themselves; in this case 
heat stable ND vaccines are highly needed (Copland, 
1987; Spradbrow, 1993/4).  
Strain I-2 of Newcastle disease virus (NDV) is a ther-
mostable vaccine which is being used to control ND in 
village chickens in developing countries (Tu et al., 1998; 
Bensink and Spradbrow, 1999; Wambura et al., 2000), 
however, it can be thermostabilized by carbohydrates 
such a trehalose in order to enhance its themostability 
and thus become less dependent on or independent of 
cold chain systems which will facilitate easy distribution of 
the vaccine. 
Trehalose is one of the most stable and chemically 
non-reactive disaccharides. It has a high thermostability 
and a wide pH-stability range. Trehalose is not hygro-
scopic; however, exhibits flash solubility on hydration, a 
property particularly useful for dried vaccines (Colaco et 
al., 1995; Higashiyama, 2002). Because of its low visco-
sity, safety and resistant to dehydration, trehalose is 
ideally suited for use in eye drop formulations (Matsuo et 
al., 2002). 
Most of dry ND vaccine formulations are in powder or 
pellet form (Rehmani et al., 1995; Corbanie et al.,  2007);  no 
  




vaccine flakes for ND vaccine have been developed so 
far. A formulation of vaccine flakes may provide a me-
dium which is inexpensive, easily prepared and is parti-
cularly useful for storage, transport and delivery of ND 
vaccine to village chicken flocks in remote are as where 
cold chain systems are inefficient or unavailable.  
The objective of the present study was to develop and 
evaluate formulation of trehalose flakes of NDV strain I-2 




MATERIALS AND METHODS 
 
Source of the virus for vaccine production 
 
I-2 vaccine is produced locally at Sokoine University of Agriculture 
(SUA). The virus was obtained from a freeze-dried master seed of 
strain I-2 of NDV. This was propagated in embryonated eggs to pro-
duce the vaccine. The strain I-2 has no commercial ownership and 
is produced and supplied by the John Francis Virus Laboratory at 




Source of eggs and propagation of strain I-2 
 
All eggs used in this study were obtained from a hatchery at De-
partment of Veterinary Microbiology, SUA. Eggs were bought when 
they were 9-day-old after incubation and were used the following 
day. The propagation of green coloured liquid I-2 vaccine was done 




Preparation of trehalose vaccine flakes 
 
The 2.5 g of trehalose (Hayashibara Biochemical Laboratories, Inc. 
Japan) were weighed in a plastic trough and 0.05 g of green dye 
(Maimun Supplies Ltd, Mombasa, Kenya) was added. After tho-
rough mixing, 2.5 mL of infective allantoic fluid with I-2 strain of 
NDV (109.7EID50/mL) was added. These ingredients were mixed 
thoroughly until a uniform trehalose saturated solution was formed. 
The solution was left to dry in a plastic trough at room temperature 
(25-34°C) for 24 h without steam condition to produce flat pieces 
called flakes. 
The vaccine flakes prepared above are enough for 5 chicken-do-
sages. Therefore to vaccinate 15 chickens 7.5 g of vaccine flakes 
were prepared.  
 
 
Storage of vaccine flakes 
 
The dried flakes were removed from the plastic trough and stored 
dried in sealed small plastic bags at room temperature (25-34ºC). 
 
 
Infectivity assay for vaccine virus in trehalose flakes 
 
Seven days after storage the flakes were removed from a plastic 
bag and they were dissolved in 3 mL of distilled water. Thereafter 
100 µL of the solution was added in 900 µL of PBS with antibiotics; 





dilution was inoculated into 5 embryonated eggs. The eggs were 
incubated at 37°C for 96 h. Thereafter the eggs were examined for 
the presence of haemagglutinin as described by Allan and Gough  
 (1974). The infectivity titre of I-2 virus was calculated as described 
previously by Reed and Muench (1938) and expressed as log10 
EID50/mL. 
The same procedure was repeated at a weekly interval up to 4 
weeks; thereafter it was done at a monthly interval. 
 
 
Source of chickens 
 
Rhode Island Red cross-bred one-day old pullets which were used 
in this study were purchased from a known ND free commercial hat-
chery in Dar es Salaam. They were raised in an animal house near 
to our laboratory. At 4 weeks of age all birds were wing-tagged and 
randomly assigned to two groups of 15 chickens each. Each group 
was separately kept in pens with concrete floors and straw litter. All 
chickens were clinically and serologically negative for ND. 
 
 
Management of chickens 
 
Chickens were kept on deep litter. They were fed chicken mash ac-




Vaccination of chicken with trehalose I-2 flakes 
 
At 4 weeks of age, the chickens in group 1 were vaccinated with the 
green-coloured vaccine flakes whereas chickens in group 2 were 
not vaccinated and served as negative controls. The vaccine was 
administered through oral route where chickens were picking 
vaccine flakes from the mat where they received nominal viral dose. 
Blood samples were collected from both birds in each group be-
fore starting the test and at a weekly interval for 4 weeks after vac-




Haemagglutination-inhibition (HI) antibody assay 
 
Test sera were inactivated at 56°C for 10 min to destroy comple-
ment and HI inhibitors. Twenty-five milliliter of double serial diluted 
test sera were then added to wells containing 25 µL of four hemag-
glutinating units of ND virus followed by adding 50 µL of 0.5% 
chicken red blood cells to each well. Plates were then incubated at 
room temperature for 1 h. The endpoint HI titer was defined as the 
reciprocal of the highest serum dilution that completely inhibited 






Four weeks after vaccination, all chickens in all groups were chal-
lenged with NDV virulent strain (103 CLD50) by inoculation into the 
nasal sinus. After challenge, the chickens were examined daily for 





Analysis of variance (ANOVA) was performed using the General 
linear model (GLM) procedure (SAS, 1986). The significance effect 
(P <0.05) of geometric mean titres (GMT) of NDV antibody between 






Table 1. Comparison of infectivity titres between liquid 
vaccine and dry vaccine flakes stored at room 




Infectivity titres (EID50/0.1mL)a 
Liquid vaccine Dry vaccine 
flakes 
0 9.7 9.7 
7 9.7 9.7 
14 8.8 9.5 
21 8.7 9.5 
28 8.6 8.6 
60 7.5 7.5 
90 7.5 7.5 
120 7.5 7.5 
 






Infectivity titres for vaccine flakes 
 
The results of the present study in Table 1 showed that 
the I-2 virus stored in trehalose flakes maintained its in-
fectivity titre at 108.6 EID 50/0.1 mL for 4 weeks at ambient 
room temperature (25-34°C) with the loss of 1.1 log10. It is 
noteworthy that the titres for liquid vaccine were slightly 
lower than those of the dry vaccine flakes; however the 
difference was not statistically significant. The vaccine 
flakes were stable after storage for 16 weeks while main-





Moreover, there were no deaths of embryos observed in 
embryonated eggs inoculated with I-2 virus stored in tre-
halose flakes after incubation for 96 h and no adverse ef-





All chickens tested prior to administration of vaccine were 
negative to HI NDV antibody. Results further indicated 
that 80% (12/15) of chickens vaccinated with I-2 vaccine 
flakes 14 days after vaccination had antibody titre of ≥3 
log2 with 2.9 GMT. However 100% (15/15) of chickens 
had a titre of ≥3 log2 with GMT of 4.3 and 4.4 at 21 and 
28 days after vaccination, respectively. All control (unvac-
cinated) chickens were negative to NDV antibody throu-





Results from the challenge trial showed that  100%  of  all  




vaccinated chickens (n=15) survived after challenge with 
virulent NDV whereas all non-vaccinated chickens (n=15) 
died within 3 days showing clinical and post-mortem 





The findings of present study showed that trehalose I-2 
vaccine flakes could be stored for 16 weeks at room tem-
perature and remained stable. These findings were com-
parable to the liquid vaccine which was stabilised by 
gelatin. The vaccine flakes were developed by using an 
amorphous trehalose sugar as a stabilizer (Bieganski et 
al., 1998; Lloyd 2000). The vaccine flakes are green co-
loured for easy visual identification and delivery to chic-
kens particularly by eye drop (Wambura, 2008a). 
Although the infectivity titres of dry (flakes) and liquid 
vaccines when stored at room temperature were not sig-
nificantly different, the dry vaccine has several advan-
tages over the latter.  The vaccine flakes are easily trans-
ported and readily released into a fluid phase when mix-
ed with water; they can be administered orally without 
mixing with feeds and hence suitable for individual or 
mass vaccination of semiferal scavenging village chic-
kens. 
Moreover, when the vaccine flakes were administered 
to chickens they proved to be safe and efficacious. It pro-
duced the protective antibody response in chickens 
against challenge with virulent NDV. The present results 
collaborate with the findings from the previous studies 
which showed that vaccination of chickens with NDV 
strain I-2 results in protection against subsequent ND 
challenge although the geometric mean titres were lower 
than those observed in green coloured liquid and oiled 
rice vaccines (Wambura, 2008a,b). The differences could 
possibly be attributed to increased efficiency of eye drop 
vaccination through the use green dye and the effect oil 
as an adjuvant, respectively. 
The development of thermostabilized dry vaccines and 
delivery technologies may help to overcome the cold sto-
rage and current distribution systems and delivery met-
hods. Dry vaccine formulations are potentially superior to 
liquid vaccines in their sterility and stability, and thus 
eliminating the need for the cold chain (LiCalsi et al., 
1999; Corbanie et al., 2007). The above facts were not 
realized in the present study therefore the technique used 
for formulation of trehalose vaccine flakes need to be 
optimized. 
The trehalose vaccine flakes could be a useful formula-
tion in order to produce a new and affordable ways to 
store and deliver ND vaccines to village chicken flocks in 
rural areas particularly in developing countries. This tech-
nology can greatly expand the availability and the cove-
rage of vaccination of chickens against ND in rural areas 
which lack basic infrastructures if it is optimized and 
adopted.  
  




Table 2. Antibody response produced by chickens vaccinated with I-2 dry vaccine flakes.  
 
Group Vaccine dose 
(EID50)a 
Antibody response at different days after vaccination 
0b 7 14 21 28 
Dry vaccine flakes  108..5 <1c 1.8±0.3 2.9±0.1 4.3±0.7 4.4±0.5 
Unvaccinated  Nil <1 <1 <1 <1 <1 
 




In conclusion, this study demonstrated that it is feasible 
to produce vaccine flakes by using trehalose and aviru-
lent thermostable strain I-2 virus of NDV. These vaccine 
flakes can be used for single and mass vaccination of vil-
lage poultry. To the best of my knowledge this the first re-
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